<html><head><meta content="text/html; charset=ISO-8859-1"http-equiv="Content-Type"><head><link rel="stylesheet" type="text/css" href="../malletgui.css" /><title>Doc191.html</title></head><table style=" text-align: left;" border="0" cellpadding="2" cellspacing="2"><tbody><body><h4><u>DOC</u> :191.txt</h4><br><textarea style="width: 50%; height: 150px;">US regulator to rule on pain drug

US food and drug regulators will decide on Friday whether to recommend the sale of painkillers that have been linked to a high risk of heart attack and stroke.

The Food and Drug Administration (FDA) advisory panel will give its verdict after hearing evidence for three days. The painkillers - called COX-2 inhibitors - are sold under brand names such as Celebrex and Vioxx. Vioxx was withdrawn from shops last year but Merck said it would consider selling it if it gets FDA approval. The FDA has been asked to decide if the benefits to patients justify the increased risks.

Putting Vioxx back on the shelves is likely to boost profits at Merck and make easier any legal battles with people who claim to have been injured by the drug, analysts said.

Merck voluntarily stopped sales of Vioxx on 30 September, a move which caused the firm's fourth-quarter earnings to slide to $1.1bn (Â£581m), from $1.4bn a year earlier. Merck's shares tumbled more than 10% on the news and the company has had to set aside millions of dollars to cover the cost of Vioxx-related litigation. Alarm bells were rung by a research note called Approve which showed that the risk of heart attack and stroke doubled in patients who had been taking the drug for at leas...</textarea><br><br>Top topics in this doc (% words in doc assigned to this topic) <br><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td><td>(41%)</td><td><a href=../Topics/Topic8.html>firms commission statement decision sec rules</a> ...</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td><td>(8%)</td><td><a href=../Topics/Topic4.html>state money added cuts make pay</a> ...</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td><td>(7%)</td><td><a href=../Topics/Topic1.html>yukos russian court oil russia bn</a> ...</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td><td>(5%)</td><td><a href=../Topics/Topic15.html>year bn profits quarter expected profit</a> ...</td></tr></tbody></table><br><br><br><br><a href=../all_topics.html><b>[Index]</b></a></body></html>